Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition

IAC Express 2011

Issue number 945: August 8, 2011

Please click here to subscribe to IAC Express as well as other FREE IAC periodicals.
Contents of this Issue
Select a title to jump to the article.
  1. New: July issue of Vaccinate Adults is now online
  2. Reminder: July issue of Needle Tips available online
  3. MMWR publishes CDC's updated recommendations for use of meningococcal conjugate vaccine
  4. IAC's Video of the Week features IAC Executive Director Dr. Deborah L. Wexler speaking about back-to-school vaccination
  5. Spotlight on immunize.org: A to Z Index
  6. FDA and manufacturers provide resources in response to advisory committees' new recommendations on safe use of acetaminophen in children
  7. Journal of Infectious Diseases publishes CDC's special supplement on global progress toward measles eradication
  8. July issue of CDC's Immunization Works newsletter now available
  9. IAC's popular laminated versions of the 2011 U.S. immunization schedules are available. Order a supply for your workplace today!
  10. Award-winning DVD! "Immunization Techniques: Best Practices with Infants, Children, and Adults"--from the California Department of Public Health, Immunization Branch
  11. Landscape analysis investigates potential drivers of strong routine immunization system performance in Africa
 
Abbreviations
AAFP, American Academy of Family Physicians; AAP, American Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices; AMA, American Medical Association; CDC, Centers for Disease Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD, National Center for Immunization and Respiratory Diseases; NIVS, National Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD, vaccine-preventable disease; WHO, World Health Organization.
  
Issue 945: August 8, 2011
1.  New: July issue of Vaccinate Adults is now online

The July issue of Vaccinate Adults is now online for downloading at http://www.immunize.org/va/va32.pdf

This issue is primarily devoted to giving healthcare professionals information they need to respond to measles outbreaks across the U.S. The issue also brings readers some of IAC's most popular resources: the latest version of the summary of immunization recommendations for adults; links to 10 of our standing orders for adult vaccine administration; and much more.

It also includes the Ask the Experts column from CDC experts Andrew T. Kroger, MD, MPH; Donna L. Weaver, RN, MN; and William L. Atkinson, MD, MPH.

To download a PDF of the entire 16-page issue of Vaccinate Adults, go to: http://www.immunize.org/va/va32.pdf

To access the Vaccinate Adults table of contents where you can view and print individual sections, go to: http://www.immunize.org/va Back issues are accessible from this page as well.
 
Back to top
   
2 Reminder: July issue of Needle Tips available online

The July issue of Needle Tips is available online for viewing, downloading, and printing.

To download the entire issue right now, go to: http://www.immunize.org/nslt.d/n49/n49.pdf

To view the table of contents, use a magazine viewer, or access back issues, go to: http://www.immunize.org/nt
 
Back to top
   
3 MMWR publishes CDC's updated recommendations for use of meningococcal conjugate vaccine

The August 5 issue of MMWR includes an article titled "Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease--Advisory Committee on Immunization Practices (ACIP), 2011." Portions of the article are reprinted below.


In January 2011, the Food and Drug Administration lowered the approval age range for use of MenACWY-CRM (Menveo, Novartis Vaccines and Diagnostics), a quadrivalent meningococcal conjugate vaccine, to include persons aged 2 through 55 years. One other quadrivalent meningococcal conjugate vaccine, MenACWY-D (Menactra, sanofi pasteur), is licensed in the United States for prevention of meningococcal disease caused by serogroups A, C, Y, and W-135 among persons aged 2 through 55 years; MenACWY-D also is licensed as a 2-dose series for children aged 9 through 23 months. The Advisory Committee on Immunization Practices (ACIP) recommends that persons aged 2 through 55 years at increased risk for meningococcal disease and all adolescents aged 11 through 18 years be immunized with meningococcal conjugate vaccine. ACIP further recommended, in January 2011, that all adolescents receive a booster dose of quadrivalent meningococcal conjugate vaccine at age 16 years. This report summarizes data supporting the extended age indication for MenACWY-CRM and the interchangeability of the two licensed meningococcal conjugate vaccines. . . .

USE OF MENINGOCOCCAL CONJUGATE VACCINE IN CHILDREN AGED 2 THROUGH 10 YEARS
ACIP recommends vaccination with meningococcal conjugate vaccine for children aged 2 through 10 years at increased risk for meningococcal disease. A 2-dose primary series is recommended for children with terminal complement deficiencies (e.g., C5-C9, properdin, factor H, or factor D deficiencies) or anatomic or functional asplenia. A single primary dose is recommended for children with increased risk for disease because they are travelers to or residents of countries in which meningococcal disease is hyperendemic or epidemic (e.g., the meningitis belt of sub-Saharan Africa). Either meningococcal conjugate vaccine can be used in children aged 2 through 10 years and both are preferred over quadrivalent meningococcal polysaccharide vaccine. This recommendation supersedes the previous recommendation that children aged 2 through 10 years should receive only MenACWY-D when meningococcal vaccination is indicated. Children aged 2 through 10 years with no increased risk for meningococcal disease are not recommended to receive any meningococcal vaccine.

INTERCHANGEABILITY OF MenACWY-CRM AND MenACWY-D
In January 2011, ACIP recommended a single booster dose of meningococcal conjugate vaccine for adolescents who received a previous dose before age 16 years. For persons aged 2 through 55 years at increased risk for meningococcal disease (i.e., persons with asplenia or terminal complement deficiencies, or laboratory workers who work with Neisseria meningitidis), a booster dose is recommended if they remain at increased risk. . . .

Healthcare providers should use every opportunity to provide the booster dose when indicated, regardless of the vaccine brand used for the previous dose or doses.


To access the ready-to-print (PDF) version of the article, go to pages 1018-1019 of this document: http://www.cdc.gov/mmwr/pdf/wk/mm6030.pdf

To access the article in web-text (HTML) format, go to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6030a3.htm
 
Back to top
   
4 IAC's Video of the Week features IAC Executive Director Dr. Deborah L. Wexler speaking about back-to-school vaccination

IAC encourages IAC Express readers to watch a 4-minute video of IAC Executive Director Deborah L. Wexler, MD, being interviewed about back-to-school vaccination. The interview recently aired on KARE 11 TV, NBC's affiliate in Minneapolis-St. Paul.

The video will be available on the home page of IAC's website through August 15. To access it, go to: http://www.immunize.org and click on the image under the words Video of the Week.

Remember to bookmark IAC's home page to view a new video every Monday.

To access the archives of IAC's Videos of the Week, go to: http://www.immunize.org/votw
 
Back to top
   
5 Spotlight on immunize.org: A to Z Index

Looking for quick access to IAC's web sections and resources? Look no further. IAC's A-to-Z Index provides an alphabetical listing of links to the majority of web sections and resources on immunize.org. At the very top of each page, you'll find the link to this handy index.

To access the A-Z Index, please visit http://www.immunize.org/a-z
 
Back to top
   
6 FDA and manufacturers provide resources in response to advisory committees' new recommendations on safe use of acetaminophen in children

On May 17-18, FDA's Nonprescription Drugs Advisory Committee and Pediatric Advisory Committee met jointly to discuss how to reduce medication errors and make children's over-the-counter (OTC) medicines that contain acetaminophen safer to use. According to an article titled "Reducing Fever in Children: Safe Use of Acetaminophen," which was published in FDA's consumer publication Consumer Health Information, the committees recommended the following:
  • That liquid, chewable, and tablet forms be made in just one strength. Currently, there are seven strengths available for these forms combined.
     
  • That dosing instructions to reduce fever be developed for children as young as 6 months. Current instructions apply to children ages 2 to 12 years and [instructions] for those under 2, only state "consult a doctor."
     
  • That dosing instructions be based on weight, not just age.
     
  • [That standards be set] for dosing devices, such as spoons and cups, for children's medicines. Currently, some use milliliters (mL) while others use cubic centimeters (cc) or teaspoons (tsp).

To access the complete FDA article, go to: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm263989.htm

In response to the committees' recommendations, OTC drug manufacturers have made resources available for healthcare professionals. Following are titles and links to some resources.

The following four links are from McNeil Consumer Healthcare (maker of Tylenol)

(1) Q&As:
http://www.tylenolprofessional.com/faqs_pediatric-product-update.html

(2) Infants' Acetaminophen Dosing Change:
http://www.tylenolprofessional.com/assets/PED_071_PedDosing_PatEd_21.pdf

(3) Children's Tylenol Dosing Chart:
http://www.tylenolprofessional.com/products/childrens-suspension-liquid.html
In the right column of the page, click on the word Dosing,and you will be taken to the chart.

(4) Letter to Healthcare Professionals--Important Update on Dosing and Concentration Changes for OTC Infants' Acetaminophen:
http://www.tylenolprofessional.com/letter_important_update_dosing_changes_for_otc_infants.html

The following link is to a briefing book submitted to FDA by the Consumer Healthcare Products Association, an industry association of manufacturers and distributors of OTC medicines and nutritional supplements:
http://www.chpa-info.org/media/resources/r_7210.pdf#search=%22Briefing%22

Back to top
   
7 Journal of Infectious Diseases publishes CDC's special supplement on global progress toward measles eradication

[The following is cross posted from the July 2011 issue of CDC's Immunization Works electronic newsletter.]


JOURNAL OF INFECTIOUS DISEASES--MEASLES SUPPLEMENT: CDC published a special supplement on global progress toward measles eradication and prevention of rubella and congenital rubella syndrome in the July 1st issue of the Journal of Infectious Diseases (JID). The supplement is a comprehensive review of the global efforts to eradicate measles and reaffirms a WHO Advisory Group conclusion that "measles can and should be eradicated." . . .

Abstracts of the articles are available online at http://jid.oxfordjournals.org/content/204/suppl_1.toc or call (404) 639-3286 to receive printed copies.

[IAC Express editor's note: IAC encourages readers who are not subscribers to JID, and who are interested in reading the full text of one or more articles in the supplement, to contact their local medical library.]


To access the July 2011 issue of CDC's Immunization Works electronic newsletter, go to http://www.cdc.gov/vaccines/news/newsltrs/imwrks/2011/201107.htm

 
Back to top
   
8 July issue of CDC's Immunization Works newsletter now available

CDC recently released the July issue of its monthly newsletter Immunization Works and posted it on the website of the National Center for Immunization and Respiratory Diseases (NCIRD). The newsletter offers the immunization community information about current topics. The information is in the public domain and can be reproduced and circulated widely.

Most articles in the July Immunization Works newsletter have been covered in this or previous issues of IAC Express.

To access the July issue, go to: http://www.cdc.gov/vaccines/news/newsltrs/imwrks/2011/201107.htm
 
Back to top
   
9 IAC's popular laminated versions of the 2011 U.S. immunization schedules are available. Order a supply for your workplace today!

IAC's laminated versions of the 2011 U.S. child/teen and adult immunization schedules are covered with a tough, washable coating that lets them stand up to a year's worth of use in every area of your workplace where immunizations are given. Each has six pages (i.e., three double-sided pages) and is folded to measure 8.5" by 11".

Laminated schedules are printed in color for easy reading, come complete with essential tables and footnotes, and include contraindications and precautions--a feature that will help you make an on-the-spot determination about the safety of vaccinating patients of any age.

PRICING
1-4 copies: $7.50 each
5-19 copies: $5.50 each
20-99 copies: $4.50 each

To view images of the laminated schedules, or to order online or download an order form, go to: http://www.immunize.org/shop/laminated-schedules.asp

For quotes on customizing or placing orders in excess of 999 schedules, call (651) 647-9009 or email admininfo@immunize.org

To learn about other essential immunization resources available for purchase from IAC, go to: http://www.immunize.org/shop
 
Back to top
   
10.  Award-winning DVD! "Immunization Techniques: Best Practices with Infants, Children, and Adults"--from the California Department of Public Health, Immunization Branch

The California Department of Public Health (CDPH), Immunization Branch, has updated its award-winning training video, "Immunization Techniques: Best Practices with Infants, Children, and Adults." The 25-minute program can be used to train new employees and to refresh the skills of experienced staff. The video demonstrates the skills and techniques needed to administer vaccines to patients of all ages.

Prices start at $17 each for 1-9 copies and are greatly reduced for large orders, dropping to $3 each for 1,000-1,499 copies.

To learn more about the DVD, and find out how to order it, go to: http://www.immunize.org/dvd

For quotes on larger quantities, call (651) 647-9009 or email admininfo@immunize.org

The Immunization Action Coalition is the only nationwide vendor of the DVD.

Note for healthcare settings located in California: Contact your local health department immunization program for a free copy.
 
Back to top
   
11.  Landscape analysis investigates potential drivers of strong routine immunization system performance in Africa

The Africa Routine Immunization System Essentials (ARISE) project, managed by John Snow, Inc. with funding from the Bill & Melinda Gates Foundation, documents successful interventions that drive strong routine immunization system performance in Africa and analyzes their potential for diffusion throughout the region. ARISE translates these tested solutions into focused options for supporting routine immunization at the global, regional, national, and sub-national levels.

As a first step, ARISE conducted a landscape analysis to identify potential drivers of strong routine immunization performance in Africa. A report of the landscape analysis, titled "Landscape Analysis Synopsis: An Initial Investigation of the Drivers of Routine Immunization System Performance in Africa" is available at
http://www.jsi.com/JSIInternet/Resources/Publications/childsurvival.cfm#immunization

According to its website, John Snow, Inc., and its nonprofit affiliate JSI Research & Training Institute, Inc., are public health research and consulting firms dedicated to improving the health of individuals and communities throughout the world.
 
Back to top
   
Immunization Action Coalition  •  Saint Paul, MN
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.